Introduction
Among the dierent types of cell-cell interaction, gap junctional intercellular communication (GJIC) is the only way by which cells can directly exchange small cytoplasmic hydrophilic metabolites (51000 Da). This transfer occurs via intercellular channels gathered into gap junction plaques and made up of juxtaposed transmembrane hemichannels (connexons) provided by adjacent cells. Each connexon is composed of six connexin (Cx) protein subunits. The connexins are encoded by genes of a family containing at least thirteen members in mammals (Dahl et al., 1996; Kumar and Gilula, 1996) and are expressed dierently in various tissues with a temporal speci®city during development or tissue dierentiation. Such spatiotemporal regulation of connexin expression suggests that they play an important role in cell dierentiation.
Various lines of evidence support the involvement of GJIC in aberrant cell dierentiation, including carcinogenesis. For instance, the inhibition of GJIC by several tumor-promoting agents and the aberrant GJIC observed in tumor cells of various kinds provide evidence for the role of disrupted GJIC in carcinogenesis and therefore in cell growth control (Yamasaki and Naus, 1996) . Another major line of evidence for the role of GJIC in negative cell growth control arises from transfection of connexin cDNA into non-communicating tumor cells. A tumor-suppressor eect of connexin 43 (Cx43) has been demonstrated in rat C6 glioma cells (Zhu et al., 1991; Naus et al., 1992) , in mouse transformed ®broblasts MCA-10 ( Rose et al., 1993) and in human mammary carcinoma cells (Hirschi et al., 1996) . Similarly, growth delay of a human hepatoma cell line was observed in vivo after Cx32 transfection (Eghbali et al., 1991) . We have shown that expression of Cx26 eliminates the tumorigenicity of HeLa cells (Mesnil et al., 1995) . The tumor-suppressor activity of the Cx26 gene in human breast cancer was also predicted (Lee et al., 1991) and has recently been con®rmed by transfection of the Cx26 gene into human mammary carcinoma cells (Hirschi et al., 1996) .
Mutations aecting connexin genes have been found to be associated with human inherited diseases, as in the case of Cx32 gene mutations in X-linked CharcotMarie-Tooth disease (a peripheral neuropathy) (Bergoen et al., 1993) . We have shown that some Cx32 mutations found in patients with this disease prevent the communication function of the protein and also prevent the communication function of the wild-type Cx32 protein in HeLa cells, by a dominant-negative eect, probably by forming heteromeric and nonfunctional connexons (Omori et al., 1996a) . Heteromeric connexons of mutated and wild-type Cx32 coexpressed in a single cell might be formed, in a similar manner to that observed between dierent types of connexins such as Cx26 and Cx32 (Stauer, 1995) or Cx43 and Cx45 (Jiang and Goodenough, 1996) . During carcinogenesis, it is possible that connexin genes are mutated and such mutant connexins may prevent the function of wild-type connexins and thus cause the loss of GJIC ability and growth control. In order to examine whether Cx26 mutants can exhibit a dominant-negative eect on the tumor growth suppression and the GJIC capacity exerted by wild-type Cx26, we double-transfected mutated and wild-type Cx26 into HeLa cells. Our results suggest that certain mutants do indeed abrogate the growth control exerted by wildtype Cx26. Furthermore, our results suggest that connexins may regulate growth control by a mechan-ism independent from the formation and function of gap junctions.
Results

Choice of mutant Cx26 genes and their transfection into HeLa cells
Three mutations of Cx26 were chosen to test their possible dominant-negative eect on the wild-type Cx26 (Figure 1 ). Two out of these three mutations are equivalent to those of Cx32 found in the X-linked Charcot-Marie-Tooth disease (Bergoen et al., 1993; Fairweather et al., 1994) . One of them changes arginine at codon 143 to tryptophan (R143W), in the third transmembrane domain, which may be involved in the pore function of the gap junctions. This mutation causes dominant-negative down-regulation of the function of wild-type Cx32 in Xenopus oocytes (Bruzzone et al., 1994) . The second one aects cysteine 60, one of six highly conserved cysteines that form intramolecular disul®de bridges, located in the ®rst extracellular domain. Mutation of this residue to phenylalanine (C60F) down-regulated the communication function of wild-type Cx32 in a dominant negative manner in HeLa cells (Omori et al., 1996a) . The third mutation we selected was a proline to lysine mutation at codon 87 (P87L), which is located in the second transmembrane domain and is highly conserved between dierent species and dierent connexins. This residue in Cx26 has been shown to be involved in voltage gating of gap junctions (Suchyna et al., 1993) .
The HeLa double transfectants expressing both wildtype Cx26 and R143W, C60F or P87L mutants are designated D(wt/R143W), D(wt/C60F) and D(wt/ P87L) respectively. HeLa cells expressing wild-type Cx26 and transfected with the empty vector, designated as D(wt/vector), were used as a control for other double transfectants in all our experiments.
Evidence for a dominant-negative eect of Cx26 mutants on wild-type Cx26-transfected HeLa cell growth in vitro and in vivo HeLa cell growth in soft agar and in nude mice is suppressed when the wild-type Cx26 gene is transfected (Mesnil et al., 1995) . In order to examine whether Cx26 mutants can reverse this growth-suppressive eect of wild-type C26, HeLa cells double-transfected with wildtype and mutant Cx26 genes were grown in soft agar or injected into nude mice to study their growth ability in vitro and in vivo, respectively (Table 1) .
The non-cloned D(wt/P87L) cell population significantly recovered an ability to grow in soft agar (62%) compared with non-cloned D(wt/vector) cells (29%), suggesting a dominant-negative eect of the P87L mutant on the loss of anchorage-independent growth capacity of wild-type Cx26 HeLa transfectants. The non-cloned D(wt/R143W) and D(wt/C60F) cells also had a higher ability to grow in soft agar (44% and 41% respectively) than non-cloned D(wt/vector) cells, showing a dominant-negative eect of these mutants on cell growth in vitro, but to a lesser extent than the P87L mutant.
When 10 6 cells from non-cloned D(wt/vector) were subcutaneously injected into nude mice, no tumor appeared in any of the four injected nude mice (Table  1) These results with non-cloned transfectants suggested that R143W and P87L but not C60F mutants are capable of eliminating the growth-suppressive eect of the wild-type Cx26. In order to further characterize the dominant-negative eects of mutant Cx26 genes on cell growth and GJIC, we cloned several double transfectants.
Isolation and characterization of double-transfectant clones
For cloning of double-transfectants, we picked up colonies growing in soft agar and expanded them for analysis. RT ± PCR was performed on the RNA of these colonies to examine the expression of mutated and wildtype Cx26 genes by using two dierent pairs of primers for the mutated and the wild-type Cx26 transcripts ( Figure 2 ). Among the clones, we chose for further studies two clones expressing both the C60F mutant and the wild-type Cx26 transcripts; one expressing the same level of mutated and wild-type Cx26 mRNA (clone 17) and the other expressing more mutated Cx26 Figure 1 Schematic representation of Cx26 and location of Cx26 mutations examined in this study Table 1 In vitro anchorage-independent growth capacity and in vivo tumorigenicity of non-cloned HeLa cells transfected with wild-type (wt) and mutated (mut) rat Cx26
Rat wt Rat mut Colonies growing Cx26 Cx26 in soft agar (%) Tumorigenicity
The number of colonies of the transfectants is presented as the percentage of the number of colonies of parental HeLa cells. 100% correspond to 9996 colonies growing in soft agar out of 20 000 HeLa cells seeded. The tumorigenicity is expressed as the number of mice bearing a tumor/number of injected mice than wild-type Cx26 mRNA (clone 4). For D(wt/ R143W), we selected one clone expressing similar levels of R143W and wild-type Cx26 transcripts (clone 18). Since no clone expressing more mutant than wild-type Cx26 mRNA was isolated for this mutant, we chose as the second clone, one expressing more wild-type Cx26 transcript than the R143W Cx26 one (clone 19). For D(wt/P87L) we chose one clone expressing the same level of P87L Cx26 and wild-type Cx26 transcript (clone 16) and a second clone expressing more mutated than wild-type Cx26 mRNA (clone 10).
To assess the localization of the Cx26 protein in double-transfected clones, indirect immuno¯uorescence staining was carried out (Figure 3 ). In all clones examined, Cx26 spots were present only at cell-cell contact areas and no aberrant intracytoplasmic or perinuclear localization was observed. These results suggest that C60F, R143W or P87L Cx26 mutants did not modify the transport and gap junction plaque formation of wild-type or mutated Cx26 proteins in the membrane of these cells.
GJIC capacity of double-transfected clones
To examine a possible dominant-negative eect of mutated Cx26 on GJIC capacity induced by wild-type Cx26, the dye transfer assay was performed by microinjecting Lucifer yellow into double-transfected clones ( Figure 4 ). The GJIC capacity of D(wt/C60F) clones 4 and 17 was diminished compared with that of the D(wt/vector) clone 3 (Table 2 ). This suggests that the C60F mutant has a dominant-negative eect on the GJIC capacity of wild-type Cx26. This is consistent with the eect of the equivalent mutant of Cx32, which also abrogated GJIC capacity in HeLa cells transfected with the wild-type Cx32 (Omori et al., 1996a) .
As shown in Table 2 , R143W and P87L mutants have no signi®cant inhibitory eect on the GJIC capacity of wild-type Cx26, although clonal variations were observed.
Growth regulation of double-transfected clones in vivo
In order to examine quantitatively the dominantnegative growth eect of mutated Cx26 genes, we injected D(wt/mutant) clones into nude mice. A dominant-negative eect of the P87L mutant on the tumor-suppressor eect of wild-type Cx26 was observed in cloned cells, as with non-cloned cells. This eect was stronger in clone 10, which expressed more mutant than wild-type Cx26 mRNA, than in No tumors grew from D(wt/C60F) clones, except a tumor from clone 17 which appeared one month after the injection of the cells into nude mice. This tumor was probably the consequence of a revertant cell population, since no wild-type or mutant Cx26 expression was detected by either RT ± PCR or immuno¯uorescence techniques (Figure 6) . A tumor was also observed from the cells of D(wt/vector) clone 3. However, no Cx26 was detected by immunofluorescence although a very low level of transcript was expressed. Some very small nodules were also observed in nude mice injected with D(wt/vector) clone 3 or D(wt/C60F) clones 4 and 17. This could be due to the fact that these clones were picked up in soft agar and thus exhibited a higher growth capacity. The tumorigenicity is expressed as the number of mice bearing a tumor/number of injected mice. The expression of wild-type and mutated Cx26 was determined by RT ± PCR 
Discussion
In this study, we have demonstrated that P87L and R143W Cx26 mutants exert a dominant-negative eect on the tumor growth suppression mediated by wildtype Cx26 without aecting the GJIC capacity. In contrast, the C60F mutant had a dominant-negative eect on GJIC capacity induced by wild-type Cx26 without aecting the tumor-suppressive eect. These results suggest a lack of correlation between the tumorsuppressive eect of Cx26 and the GJIC capacity of this connexin. This apparent discrepancy between the tumorsuppression eect and the GJIC capacity of Cx26 suggests that Cx26 may exert cell growth control independently from the formation of gap junctions. We have previously suggested that dierent connexin genes exert dierential growth eects even if they are apparently from GJIC of similar capacities (Mesnil et al., 1995) . We estimated the level of GJIC based on the ability of the cells to transfer microinjected Lucifer yellow molecules, but the transfer of other molecules or ions does not necessarily parallel that of Lucifer yellow. It has indeed been shown that gap junctions of HeLa cells formed by dierent connexin species have qualitatively dierent permeability when studied with dierent tracer dyes (Elfgang et al., 1995) . Thus, GJIC in D(wt/P87L) and D(wt/R143W) may theoretically dier from that of the parental Cx26 HeLa cells in a way that would aect cell growth, without being detectable by Lucifer yellow transfer. On the other hand, another mutant, i.e. D(wt/C60F) clearly showed the loss of GJIC but not of growth control. There was thus no correlation between GJIC ability measured by Lucifer yellow and tumor growth ability in the double transfectants of all mutants used. Therefore, it is more reasonable to consider that Cx26 functions by independent mechanisms for cell growth regulation and gap junction formation. In the present study, we selected double transfectant clones for their capacity to grow in soft agar without considering their GJIC ability. This procedure may have introduced a selective bias for those cells which have a lack of correlation between tumor growth suppression and GJIC; in soft agar, GJIC is probably irrelevant for growth control.
Our observation that connexins may participate in growth control independent from GJIC formation has a certain similarity to the function of b-catenin, which is a component of another cell-cell interaction system, i.e., adherens junctions. b-Catenin is a component of cadherin complexes, but also mediates the WNT signal transduction pathway (Sanson et al., 1996) . Another study has suggested that b-catenin binds to the transcription factor LEF-1 and such a complex is considered to translocate to the nucleus and play a role in gene regulation (Behrens et al., 1996) . In analogy, de-Feijter et al., (1996) have shown that Cx43 molecules are localized in the nucleus of src-or neutransformed epithelial cells, suggesting their direct involvement in signal transduction. On the other hand, it has been shown that connexins and cadherins are reciprocally dependent on each other to fully function (Jongen et al., 1991) . Therefore, it is also possible that connexins transmit signals to the nucleus via a cadherin/catenin pathway.
We observed that D(wt/P87L) clone 10, which expresses more mutated mRNA than wild-type mRNA, had a stronger dominant-negative eect on the tumor growth control than clone 16 which expressed equivalent levels of wild-type and mutated transcripts. This suggests that the dominant-negative eect of the mutated protein depends on its level of expression. Similarly, the dominant-negative eect of R143W on cell growth regulation was observed only with D(wt/ R143W) clone 18, which expressed equivalent levels of wild-type and mutated mRNA and not in D(wt/143W) clone 19 which expressed essentially wild-type Cx26. These results suggest a good correlation between the level of mutant Cx26 expression and growth control. On the other hand, there was no such dose-eect in the down-regulation of GJIC by the C60F mutant. Indeed, the D(wt/C60F) clone 17, which expressed equivalent levels of wild-type and mutated Cx26 mRNA, and the D(wt/C60F) clone 4, which expressed more mutated than the wild-type Cx26 mRNA exhibited a similar GJIC capacity. These results further con®rm the independent behavior of Cx26 with respect to cell growth control and to GJIC modulation.
The abrogation of the tumor-suppressive eect of wild-type Cx26 by P87L or R143W mutants and the reduction of GJIC capacity by C60F may be due to the formation of heteromeric connexons or of heterotypic connexons. Cx32 mutants (C60F, V139M and R215W) have a reduced ability to form immunoreactive gap junctions in HeLa cells compared with wild-type Cx32 Cx26 dominant-negative mutation and cell growth control A Duflot-Dancer et al (Omori et al., 1996a) . This suggests that mutated proteins can form less ecient connexons properly inserted in the membrane. When these Cx32 mutants were double-transfected into the Cx32 HeLa cells, the immunostaining for Cx32 at the cell-cell contact areas was decreased, suggesting that mutated Cx32 formed heteromeric connexons with wild-type Cx32 but that these chimeric connexons had some diculty in becoming properly inserted into the membrane (Omori et al., 1996a) . In the present study, however, HeLa cells transfected with wild-type and mutated Cx26 exhibited strong staining for gap junction plaques of Cx26 at cell-cell contact areas. This means that if heteromeric connexons of mutated and wild-type Cx26 were formed, they were properly inserted into the membrane as well as homomeric connexons of wildtype Cx26, although the GJIC function was altered in the case of the C60F mutant. Why mutated Cx26, but not mutated Cx32 molecules, can be localized at the cell-cell contact area is not clear. Although it is likely that heteromeric connexons were formed between wildtype and mutant Cx26 in our study, we cannot exclude that heterotypic connexons of Cx26, i.e. ones composed of purely wild-type or mutant Cx26, could also be formed between cells.
In the present study, only the C60F mutant of the Cx26 down-regulated GJIC of Cx26 HeLa cells. However, intriguingly, the GJIC capacity of D(wt/ P87L) and D(wt/R143W) cells was unchanged compared with controls as shown by the dye transfer assay. It has been demonstrated that oocytes expressing the Cx26 P87L mutant communicating with ones expressing wild-type Cx26 have a level of intercellular conductance only one sixth of that observed between oocytes both expressing the wild-type Cx26 (Suchyna et al., 1993) . Moreover, the R143W mutant of Cx26 completely inhibits the junctional conductance, compared with oocyte pairs expressing only wild-type Cx32 (Bruzzone et al., 1994) . This apparent dierence in results may be related to the types of cell and/or species used.
Our results demonstrate that mutated connexins can prevent the growth inhibition exerted by wild-type connexins. They also suggest that during carcinogenesis, mutations aecting only one allele of a connexin gene might be sucient to modify the growth regulation capacity of the cells, in contrast to the eects of other types of tumor-suppressor genes. However, up to now, mutations of connexins have rarely been found in cancer cells. One mutation at codon 220 of Cx32 was detected in one out of 12 rat liver tumors studied (Omori et al., 1996b) . Three out of 25 rat hemangiosarcomas showed a mutation at codon 319 of Cx37 (Saito et al., 1997) . But no mutation of Cx32 has been observed either in 20 human liver tumors or in 22 human stomach tumors (Krutovskikh et al., 1994; Mironov et al., 1994) . Similarly, no mutation was found in Cx43 of 49 human meningiomas (Sato et al., 1997) . In 18 human breast carcinomas and eight human lung adenocarcinomas, no mutation of Cx37 was found (Krutovskikh et al., 1996) . Since most tumors show aberrant GJIC, the fact that connexin gene mutations are rare suggests that other mechanisms by which GJIC is controlled are disrupted during carcinogenesis; in fact, many tumors show aberrant localization, rather than mutation, of connexins. However, only three connexins Cx32, 43 and 37 have been examined for the presence of mutations and no data are available for the other 10 connexins.
Materials and methods
Expression vector construction and site-directed mutagenesis
The rat Cx26 cDNA insert containing the entire coding region was excised from pGEM-blue vector (Zhang and Nicholson, 1989) with EcoRI and subcloned into the pcDNA 3 expression vector under control of the CMV promoter (Invitrogen, San Diego, CA). Site-directed mutagenesis, based on the unique site elimination procedure (Deng and Nickolo 1992) , was performed with a USE mutagenesis kit (Pharmacia Biotech, Uppsala, Sweden) to introduce the desired mutations into rat Cx26 cDNA contained in the pcDNA 3 vector. All mutations were veri®ed by DNA sequencing.
Cell culture and cDNA transfection
Human cervix carcinoma HeLa cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) (GIBCO, Paisley, Scotland) supplemented with L-glutamine, penicillin-streptomycin (GIBCO) and 10% fetal calf serum (Dutcher, Brumath, France) . Cell cultures were incubated at 378C under a humidi®ed 5% CO 2 atmosphere and were routinely subcultured by trypsinization with a change of medium twice weekly. HeLa cells were transfected with coding cDNA of rat Cx26 inserted into the pBEHpac18 vector under control of the SV40 early promoter, a generous gift of Dr K Willecke (Elfgang et al., 1995) . To obtain double transfectants, 10 6 HeLa Cx26 cells were transfected with 5 mg each of the three mutated rat Cx26 genes inserted into pcDNA 3 by the Lipofectin reagent (GIBCO) as described by Fegner et al., (1987) . Empty pcDNA 3 vector was also transfected as a control.
RNA extraction and RT PCR analysis
RNA was isolated from con¯uent cultures or tumor tissue according to Chomczynki and Sacchi (1987) with TRIzol reagent (GIBCO, Paisley, Scotland). Moloney murine leukemia virus reverse transcriptase (M-MLV RT) (Promega, Madison, WI) was incubated at 378C with 500 ng of RNA template to generate cDNA using 150 pmol of reverse primer pCx26 5'-CTTGTTGA-CACCCCCGAGGA-3' derived from rat Cx26 sequence. PCR ampli®cation was performed on cDNA obtained by reverse transcription with 50 pmol of each primer in a volume of 50 ml according to Perkin Elmer conditions. Oligonucleotide primers pCMV 5'-GCTTGGTACCGA-GCTCGGAT-3' located in a CMV promoter sequence of pcDNA 3 vector and pCx26 were used to amplify a fragment (370 bp) of the cDNA corresponding to mRNA of mutated Cx26 gene contained in pcDNA 3 plasmid. Primers pSV40 5'-TTGGAGGCCTAGGCTTTTGC-3' located in the SV40 early promoter sequence of pBEHpac18 vector and pCx26 were used to amplify a fragment (280 bp) of the cDNA corresponding to mRNA expression of the wild-type Cx26 gene contained in pBEHpac18 plasmid. Two dierent amplication programmes were used for ampli®cation of either mutated Cx26 in pcDNA 3 plasmid or wild-type Cx26 in pBEHpac18 plasmid: initial denaturation at 948C for 5 min followed by 35 cycles of 948C denaturation for 30 s, 588C annealing for 1 min (with pSV40 and pCx26 primers) or 608C annealing for 1 min (with pCMV and pCx26 primers) and 728C extension for 1 min. The ®nal extension was for 10 min at 728C.
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Indirect immuno¯uorescence staining of cultured cells and tumors
Cells were seeded on tissue culture chambers (Lab-Tek; Nunc Inc., Naperville, IL), washed with Ca 2+ /Mg 2+ -free phosphate buered saline (PBS), and ®xed in pure acetone for 5 min at 7208C. They were then washed and incubated in a blocking solution (3% bovine serum albumin; Sigma) for 30 ± 45 min. Primary puri®ed rabbit polyclonal antibody against connexin 26, a kind gift from Dr Y Shibata (Kyushu University, Kyushu, Japan), in PBS was added to cultures at a ®nal dilution of 1:200, which were then kept for 1 h at 378C in a humidi®ed chamber. Incubations with a second biotinylated antibody directed against rabbit immunoglobulin at a ®nal dilution of 1:500 (Serva Feinbiochemica GmbH, Heidelberg, Germany) and then with a streptavidin-FITC conjugate (Serva) at a ®nal dilution of 1:100 were both performed for 1 h at 378C in a humidi®ed chamber. After extensive washing in PBS, the preparations were kept in glycerol-PBS (90/10%) containing p-phenylenediamine (pH 8.0) (Sigma) and stored at 7208C before observation under a¯uorescence/phase contrast Olympus Vannox T microscope. Micrographs were taken on Ilford HP5 (ASA 400) ®lm. A similar procedure was used for tumor tissue.
Dye transfer assay to measure GJIC capacity
To determine GJIC of cultured cells, a 5% (w/v) solution of Lucifer yellow CH (Sigma) in 0.33 M lithium chloride was transferred to a glass needle prepared from capillary tube (AM Systems Inc., Everett, WA). Cells were impaled and needles and dye was injected continuously for 0.8 s under air pressure (600 ± 800 hPa), using an Eppendorf microinjector Model 5242 (Hamburg, Germany); after 10 min the intercellular transfer of¯uorescent Lucifer yellow was estimated under an Olympus IMT-2 phasecontrast and¯uorescence microscope as described previously . For each experimental point, at least 10 microinjections were performed.
Anchorage-independent growth assay
This test was performed in soft agar (Agar Noble; DIFCO Laboratories, Detroit, MI) by seeding 2610 4 cells from each line in 4 ml of complete Dulbecco's MEM containing 0.3% agar on a solidi®ed (0.5%) basal layer (5 ml) in 60 mm dishes. Two weeks after seeding, the colonies containing at least 20 cells were counted in triplicate plates.
Tumorigenicity assay in nude mice
Suspensions of 10 6 parental or transfected HeLa cells in PBS (100 ml) were injected subcutaneously into the back of athymic nude mice (IFFA CREDO, L'Arbresle, France). After injection, each mouse was observed individually, and tumor growth was estimated by direct measurement (cm 3 ) twice per week. Mice bearing tumors of more than 5 cm 3 or 3 months old were killed and autopsied. Some tumors were analysed for mRNA expression and localization of connexin.
